First Point-of-Care Test for Serious Hemoglobin Disorder, Beta Thalassemia, Provides New Weapon for the Front Lines of Healthcare Worldwide
Hemex Health announced a major enhancement to its Gazelle platform that allows its Hb Variant test to detect beta thalassemia disease and trait in addition to sickle cell disease and trait. The enhanced Hb Variant test detects beta thalassemia with accuracy cl